|
Astec Lifesciences Ltd.
|
Income Statement
|
|
|
You can view the
Income Statement
for the last 5 years.
|
Market Cap. (Rs.)
|
2412.91 Cr.
|
P/BV
|
5.75
|
Book Value (Rs.)
|
213.86
|
|
52 Week High/Low (Rs.)
|
1542/825
|
FV/ML
|
10/1
|
P/E(X)
|
94.39
|
|
Bookclosure
|
26/07/2023
|
EPS (Rs.)
|
13.04
|
Div Yield (%)
|
0.12
|
|
(Rs. in Crs.)
| Months | 12 | 12 | 12 | 12 | 12 |
| Source Of Info (AR = Annual Report, PR = Press Release) | AR | AR | AR | AR | AR |
| FaceValue | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 |
| | | | | | |
| | | | | | |
| INCOME | | | | | |
| Revenue From Operations [Net] | 628.17 | 676.57 | 554.87 | 522.61 | 430.90 |
| Total Operating Revenues | 628.17 | 676.57 | 554.87 | 522.61 | 430.90 |
| | | | | | |
| Other Income | 13.06 | 10.47 | 7.92 | 11.93 | 11.16 |
| Total Revenue | 641.23 | 687.03 | 562.79 | 534.54 | 442.06 |
| | | | | | |
| EXPENSES | | | | | |
| Cost Of Materials Consumed | 460.83 | 444.82 | 344.60 | 333.44 | 295.05 |
| Purchase Of Stock-In Trade | 0.00 | 0.00 | 0.00 | 0.37 | 0.00 |
| Changes In Inventories Of FG,WIP And Stock-In Trade | -59.59 | -58.00 | -2.55 | 4.73 | -15.56 |
| Employee Benefit Expenses | 52.26 | 50.31 | 38.35 | 29.92 | 25.10 |
| Finance Costs | 20.71 | 9.06 | 4.75 | 12.59 | 12.38 |
| Depreciation And Amortisation Expenses | 33.65 | 34.36 | 25.66 | 23.16 | 19.35 |
| Other Expenses | 98.41 | 85.37 | 62.92 | 68.97 | 49.84 |
| Total Expenses | 606.28 | 565.91 | 473.72 | 473.19 | 386.15 |
| | | | | | |
| Profit/Loss Before Exceptional, ExtraOrdinary Items And Tax | 34.95 | 121.13 | 89.07 | 61.35 | 55.90 |
| | | | | | |
| Profit/Loss Before Tax | 34.95 | 121.13 | 89.07 | 61.35 | 55.90 |
| | | | | | |
| Tax Expenses-Continued Operations | | | | | |
| Current Tax | 0.03 | 28.63 | 23.26 | 16.07 | 15.31 |
| Deferred Tax | 9.33 | 2.61 | -0.61 | -3.05 | 4.43 |
| Tax For Earlier Years | 0.00 | 0.00 | 1.35 | 0.80 | 0.40 |
| Total Tax Expenses | 9.35 | 31.24 | 24.00 | 13.83 | 20.14 |
| Profit/Loss After Tax And Before ExtraOrdinary Items | 25.59 | 89.88 | 65.07 | 47.53 | 35.77 |
| | | | | | |
| Profit/Loss From Continuing Operations | 25.59 | 89.88 | 65.07 | 47.53 | 35.77 |
| | | | | | |
| Profit/Loss For The Period | 25.59 | 89.88 | 65.07 | 47.53 | 35.77 |
| | | | | | |
| Minority Interest | -0.03 | -0.02 | -0.02 | -0.02 | -0.03 |
| Consolidated Profit/Loss After MI And Associates | 25.56 | 89.86 | 65.05 | 47.51 | 35.74 |
| | | | | | |
| OTHER INFORMATION | | | | | |
| | | | | | |
| EARNINGS PER SHARE | | | | | |
| Basic EPS (Rs.) | 13.04 | 45.87 | 33.23 | 24.29 | 18.28 |
| Diluted EPS (Rs.) | 13.04 | 45.85 | 33.21 | 24.27 | 18.26 |
| | | | | | |
| DIVIDEND AND DIVIDEND PERCENTAGE | | | | | |
| Equity Share Dividend | 2.94 | 2.94 | 2.94 | 2.93 | 2.93 |
| Tax On Dividend | 0.00 | 0.00 | 0.00 | 0.60 | 0.60 |